Applied DNA Sciences, Inc.
APDN
$5.37
-$0.14-2.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.30M | -2.64M | -3.30M | 1.88M | -4.47M |
| Total Depreciation and Amortization | 118.70K | 58.60K | 77.00K | 134.20K | 186.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -76.20K | -231.30K | 164.40K | -5.16M | 1.04M |
| Change in Net Operating Assets | 76.70K | -513.90K | -193.70K | -348.70K | 30.50K |
| Cash from Operations | -3.19M | -3.33M | -3.25M | -3.49M | -3.21M |
| Capital Expenditure | -185.30K | -116.90K | -371.30K | -21.80K | -14.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -185.30K | -116.90K | -371.30K | -21.80K | -14.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 899.20K | 6.31M | -- | 10.81M | 2.93M |
| Repurchase of Common Stock | -- | -- | -390.70K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 80.60K |
| Cash from Financing | 899.20K | 6.31M | -390.70K | 10.81M | 3.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.47M | 2.86M | -4.01M | 7.29M | -209.40K |